Applied Genetics Technologies Corporation (AGTC) is developing therapies designed to transform the lives of patients with severe diseases, offering hope to patients with unmet medical needs. With a highly specialized team of physicians and researchers, They use cutting-edge techniques to develop treatments for patients that have diseases caused by broken genes. They use gene therapy, which replaces those broken genes with normal functional genes, allowing a patientâ??s own body to produce proteins to treat their illness. A single injection provides long-lasting treatment, leading to a better quality of life for patients worldwide.
Sector:
Health Technology
Industry:
Pharmaceuticals Generic
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Applied Genetic Technologies Corp?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Applied Genetic Technologies Corp market cap is $26.62M.
What is the 52-week high for Applied Genetic Technologies Corp?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Applied Genetic Technologies Corp 52 week high is $2.83 as of September 12, 2025.
What is the 52-week low for Applied Genetic Technologies Corp?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Applied Genetic Technologies Corp 52 week low is $0.2303 as of September 12, 2025.
What is Applied Genetic Technologies Corp stock price today?
Applied Genetic Technologies Corp stock price today is $0.3936.
What was Applied Genetic Technologies Corp stock price yesterday?
Applied Genetic Technologies Corp stock price yesterday was $0.3888.
What is the PE ratio of Applied Genetic Technologies Corp?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Applied Genetic Technologies Corp’s P/E ratio is -0.28.
What is the Price-to-Book ratio of Applied Genetic Technologies Corp?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Applied Genetic Technologies Corp P/B ratio is 1.5086.
What is the 50-day moving average of Applied Genetic Technologies Corp?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Applied Genetic Technologies Corp 50-day moving average is $0.3353.
